No Image 16Apr

by

2025/04/16

(기타)유앤팩 - 감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(유가)동성제약 - 주요사항보고서(유상증자결정)

No Image 16Apr

by

2025/04/16

(기타)현대카드유니버스제3차유동화전문유한회사 - 자산유동화관련중요사항발생등보고서(기타)

No Image 16Apr

by

2025/04/16

(기타)현대카드유니버스제2차유동화전문유한회사 - 자산유동화관련중요사항발생등보고서(기타)

No Image 16Apr

by

2025/04/16

(기타)현대카드유니버스제1차유동화전문유한회사 - 자산유동화관련중요사항발생등보고서(기타)

No Image 16Apr

by

2025/04/16

(기타)애로우잉글리시 - 감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(코스닥)CBI - 주요사항보고서(유상증자결정)

No Image 16Apr

by

2025/04/16

(기타)퀀타피아 - [기재정정]주요사항보고서(감자결정)

No Image 16Apr

by

2025/04/16

(기타)우상개발 - 감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(기타)현보 - 연결감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(기타)원진비엠티 - [기재정정]감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(기타)나우로보틱스 - 투자설명서

No Image 16Apr

by

2025/04/16

(기타)참트레이딩 - 동일인등출자계열회사와의상품ㆍ용역거래변경

No Image 16Apr

by

2025/04/16

(기타)삼성월드 - 감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(코스닥)레몬 - [기재정정]증권신고서(합병)

No Image 16Apr

by

2025/04/16

(코스닥)CMG제약 - 투자판단관련주요경영사항 (메조피(Mezofy) 미국 식품의약국(FDA) 품목허가 획득)

No Image 16Apr

by

2025/04/16

(기타)이디비 - [기재정정]감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(코넥스)바이오텐 - 신규시설투자등

No Image 16Apr

by

2025/04/16

(기타)대현우드 - 감사보고서 (2024.12)

No Image 16Apr

by

2025/04/16

(유가)엑시큐어하이트론 - [첨부정정]주요사항보고서(전환사채권발행결정)